Entity Common Stock, Shares Outstanding of PRESSURE BIOSCIENCES INC from Q2 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
PRESSURE BIOSCIENCES INC quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q4 2024.
  • PRESSURE BIOSCIENCES INC Entity Common Stock, Shares Outstanding for the quarter ending 31 Jan 2025 was 41M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

PRESSURE BIOSCIENCES INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 41M 31 Jan 2025 10-Q 07 Feb 2025
Q3 2024 37.4M +15.7M +72% 26 Aug 2024 10-Q 06 Sep 2024
Q2 2024 34.7M +16.9M +95.4% 04 Jun 2024 10-K 07 Jun 2024
Q3 2023 21.7M 10 Nov 2023 10-Q 20 Nov 2023
Q2 2023 17.8M +8.69M +95.7% 04 Aug 2023 10-Q 21 Aug 2023
Q1 2023 15.9M +7.16M +82.1% 31 Mar 2023 10-K 12 Apr 2023
Q4 2022 11.1M 18 Nov 2022 10-Q 21 Nov 2022
Q2 2022 9.07M +2.7M +42.4% 08 Aug 2022 10-Q 15 Aug 2022
Q1 2022 8.71M +4.39M +102% 31 Mar 2022 10-K 05 Apr 2022
Q3 2021 7.39M +3.51M +90.3% 10 Nov 2021 10-Q 17 Nov 2021
Q2 2021 6.37M +3.21M +102% 11 Aug 2021 10-Q 18 Aug 2021
Q1 2021 4.32M +1.55M +56% 08 Apr 2021 10-K 15 Apr 2021
Q3 2020 3.88M 12 Nov 2020 10-Q 16 Nov 2020
Q2 2020 3.16M +1.22M +63% 24 Jun 2020 10-Q 29 Jun 2020
Q1 2020 2.77M +1.07M +63% 09 Apr 2020 10-K 14 Apr 2020
Q4 2019 2.4M 10 Dec 2019 10-Q 13 Dec 2019
Q2 2019 1.94M +373K +23.8% 07 Aug 2019 10-Q 15 Aug 2019
Q1 2019 1.7M +331K +24.2% 12 Apr 2019 10-K 16 Apr 2019
Q3 2018 1.75M +597K +51.8% 07 Nov 2018 10-Q 14 Nov 2018
Q2 2018 1.57M +463K +42% 07 Aug 2018 10-Q 14 Aug 2018
Q1 2018 1.37M -30.3M -95.7% 23 Mar 2018 10-K 02 Apr 2018
Q3 2017 1.15M -29.7M -96.3% 07 Nov 2017 10-Q 13 Nov 2017
Q2 2017 1.1M -27.9M -96.2% 11 Aug 2017 10-Q 14 Aug 2017
Q1 2017 31.6M +8.43M +36.3% 17 Mar 2017 10-K 22 Mar 2017
Q3 2016 30.9M +9.38M +43.7% 11 Nov 2016 10-Q 14 Nov 2016
Q2 2016 29M +7.87M +37.2% 12 Aug 2016 10-Q 15 Aug 2016
Q1 2016 23.2M +4.14M +21.7% 01 Apr 2016 10-K 05 Apr 2016
Q3 2015 21.5M +5.7M +36.1% 10 Nov 2015 10-Q 12 Nov 2015
Q2 2015 21.2M +5.69M +36.8% 13 Aug 2015 10-Q 14 Aug 2015
Q1 2015 19.1M +6.45M +51.1% 31 Mar 2015 10-K 31 Mar 2015
Q3 2014 15.8M +3.84M +32.1% 14 Nov 2014 10-Q 14 Nov 2014
Q2 2014 15.5M +4.03M +35.2% 14 Aug 2014 10-Q 14 Aug 2014
Q1 2014 12.6M +475K +3.91% 31 Mar 2014 10-K 31 Mar 2014
Q3 2013 11.9M +254K +2.18% 30 Oct 2013 10-Q 07 Nov 2013
Q2 2013 11.4M +813K +7.64% 14 Aug 2013 10-Q 15 Aug 2013
Q1 2013 12.1M +1.79M +17.3% 31 Mar 2013 10-K 13 May 2013
Q3 2012 11.7M +5.14M +78.4% 31 Oct 2012 10-Q 14 Nov 2012
Q2 2012 10.6M +7.76M +270% 01 Aug 2012 10-Q/A 10 Sep 2012
Q1 2012 10.4M 11 May 2012 10-Q 15 May 2012
Q3 2011 6.56M 11 Nov 2011 10-Q 14 Nov 2011
Q2 2011 2.87M 21 Jul 2011 10-Q 15 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.